SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-276184
Filing Date
2023-11-13
Accepted
2023-11-13 17:08:30
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d233210ds3.htm S-3 287790
2 EX-4.3 d233210dex43.htm EX-4.3 290400
3 EX-5.1 d233210dex51.htm EX-5.1 26710
4 EX-23.1 d233210dex231.htm EX-23.1 1538
5 EX-FILING FEES d233210dexfilingfees.htm EX-FILING FEES 37892
6 GRAPHIC g233210g66f11.jpg GRAPHIC 34057
7 GRAPHIC g233210snap1.jpg GRAPHIC 14197
8 GRAPHIC g233210snap3.jpg GRAPHIC 5744
  Complete submission text file 0001193125-23-276184.txt   720191
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275519 | Film No.: 231399964
SIC: 2834 Pharmaceutical Preparations